As a single marker, IL-2 levels could be used as a potential biomarker for PDAC TLS formation, as analysis of paired blood and tumor samples from PDAC patients revealed the existence of a “stroma-to-serum” gradient in patients that lack TLS and an association between lower serum IL-2 levels and TLS formation (99). This evidence concerns the gene IL2 and neoplasm.